Meyer Handelman Co. Reduces Position in Procter & Gamble Company (The) $PG

Meyer Handelman Co. decreased its holdings in Procter & Gamble Company (The) (NYSE:PG) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 514,607 shares of the company’s stock after selling 22,853 shares during the quarter. Procter & Gamble makes up 2.3% of Meyer Handelman Co.’s portfolio, making the stock its 11th biggest position. Meyer Handelman Co.’s holdings in Procter & Gamble were worth $73,748,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Halbert Hargrove Global Advisors LLC acquired a new position in shares of Procter & Gamble in the 3rd quarter valued at approximately $25,000. Saranac Partners Ltd acquired a new stake in shares of Procter & Gamble during the third quarter worth approximately $30,000. Corundum Trust Company INC bought a new stake in shares of Procter & Gamble in the third quarter worth $32,000. Caitlin John LLC acquired a new stake in Procter & Gamble in the third quarter valued at $34,000. Finally, Marquette Asset Management LLC bought a new position in Procter & Gamble during the 3rd quarter valued at $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: OLAY peptide research — New clinical and mechanistic data presented for OLAY highlight proprietary peptide technology and cell‑adhesion targets that P&G plans to move rapidly into formulations; successful commercialization could bolster pricing power and organic growth for a core beauty brand. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
• Positive Sentiment: Analysts remain constructive in places — coverage notes that P&G can fare better than peers amid sluggish consumer sentiment, supporting the view of PG as a relatively defensive consumer staples holding. Analysts Constructive on The Procter & Gamble (PG) Amid Sluggish Consumer Sentiment
• Neutral Sentiment: Recent trading strength — PG ticked higher while the broader market fell on 3/30, showing relative strength that may reflect defensive demand; however this was a short‑term move rather than new fundamental news. Procter & Gamble (PG) Ascends While Market Falls: Some Facts to Note
• Neutral Sentiment: Q4 results mixed — Q4 EPS slightly beat estimates (+$0.02) while revenue marginally missed; steady margins and cash flow help the case for the dividend and buybacks, but top‑line softness tempers upside. (Earnings detail from recent company report.)
• Neutral Sentiment: Deutsche Bank trimmed its price target (from $171 to $162) but kept a Hold — this narrows upside but is not a sell signal; investors should weigh this against other analyst views. Deutsche Bank Lowers Price Target on PG
• Neutral Sentiment: Unrelated retailer weakness — a separate report on RH’s weak quarter is unlikely to directly affect PG but signals broader discretionary‑spending challenges in retail. RH (RH) Lags Q4 Earnings and Revenue Estimates
• Negative Sentiment: TD Cowen cut its price target to $142 (from $156) and kept a Hold, citing oil‑linked input cost inflation tied to the Iran war that it believes P&G cannot fully absorb — this is the main near‑term headwind pressuring the stock. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on PG shares. BNP Paribas Exane dropped their target price on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a research report on Friday, January 16th. Erste Group Bank downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Tuesday, March 24th. Barclays set a $155.00 price objective on Procter & Gamble in a report on Friday, January 16th. Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Finally, UBS Group lifted their target price on Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a research report on Friday, January 23rd. Twelve research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $167.83.

Procter & Gamble Stock Performance

Shares of PG opened at $144.44 on Wednesday. The firm has a fifty day moving average of $153.88 and a 200-day moving average of $149.88. The company has a market cap of $335.67 billion, a price-to-earnings ratio of 21.40, a price-to-earnings-growth ratio of 4.84 and a beta of 0.37. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $174.80.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.02. The firm had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. Procter & Gamble’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period last year, the firm posted $1.88 EPS. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were given a dividend of $1.0568 per share. The ex-dividend date was Friday, January 23rd. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. Procter & Gamble’s payout ratio is currently 62.52%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Gary A. Coombe sold 36,093 shares of the business’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the completion of the transaction, the chief executive officer owned 34,994 shares in the company, valued at approximately $5,680,576.02. The trade was a 50.77% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Marc S. Pritchard sold 95,903 shares of the stock in a transaction on Friday, January 23rd. The stock was sold at an average price of $151.15, for a total value of $14,495,738.45. Following the completion of the transaction, the insider directly owned 182,607 shares of the company’s stock, valued at approximately $27,601,048.05. The trade was a 34.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 348,618 shares of company stock valued at $55,462,643. 0.20% of the stock is currently owned by insiders.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.